ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1217

The Problem of Pain in Rheumatology: Clinical Profiles Associated with Concomitant Diagnoses with Chronic Overlapping Pain Conditions

Titilola Falasinnu1, Yashaar Chaichian2 and Julia Simard3, 1Stanford School of Medicine, Stanford, CA, 2Stanford University, Stanford, CA, 3Stanford University School of Medicine, Palo Alto, CA

Meeting: ACR Convergence 2022

Keywords: autoimmune diseases, Demographics, Epidemiology, Outcome measures, pain

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2022

Title: Fibromyalgia and Other Clinical Pain Syndromes Poster

Session Type: Poster Session C

Session Time: 1:00PM-3:00PM

Background/Purpose: The chronification of pain is heterogeneous in rheumatology. Chronic overlapping pain conditions (COPCs) such as fibromyalgia, endometriosis, migraine, and back pain may co-occur with one another and in rheumatic diseases. We describe the sociodemographic and clinical profiles associated with concomitant COPCs among patients with rheumatic diseases.

Methods: We retrospectively identified patients visiting rheumatology clinics at a single institution from 2010 to 2020 for five common rheumatic conditions: psoriatic arthritis (PsA), rheumatoid arthritis (RA), Sjögren’s syndrome (SjS), systemic lupus erythematosus (SLE), and systemic sclerosis (SSc). We compared sociodemographic, clinical and lifestyle factors by rheumatic condition and by COPC status. We also report sex-stratified diagnosis of COPCs. The primary outcome was diagnostic validation of >1 COPC.

Results: We identified 5992 rheumatology patients: n=846 PsA, n=2605 RA, n=956 SjS, n=975 SLE, and n=610 SSc. >50% of patients had concomitant COPC diagnosis. Patients with SjS had the highest prevalence: 62%. Diagnosis of ≥1 COPC was highest among Black patients, and lowest among Asian patients. Patients using public insurance had a higher prevalence of ≥1 COPC compared to those with private insurance. Patients with ≥1 COPC had more depression and anxiety and more frequent ED visits, surgeries, and hospitalizations.

Conclusion: Our findings suggest that COPCs are strikingly common among patients with rheumatic disease and are associated with lower quality of life and greater healthcare needs. Future research may elucidate drivers of chronic pain and how to best address the unique analgesic needs of this multimorbid population.

Supporting image 1

Table 1. Sex-stratified concomitant diagnoses of chronic overlapping pain conditions among patients with rheumatic diseases managed at an academic medical center, 2010_2020*

Supporting image 2

Table 2. Concomitant diagnoses of chronic overlapping pain conditions by demographic factors among patients with rheumatic diseases at an academic medical center, 2010_2020*

Supporting image 3

Table 3. Concomitant diagnosis of chronic overlapping pain conditions by age, mental health diagnosis and health utilization among patients with rheumatic diseases at an academic medical center, 2010_2020


Disclosures: T. Falasinnu, None; Y. Chaichian, Amgen, Eli Lilly, Boehringer-Ingelheim; J. Simard, None.

To cite this abstract in AMA style:

Falasinnu T, Chaichian Y, Simard J. The Problem of Pain in Rheumatology: Clinical Profiles Associated with Concomitant Diagnoses with Chronic Overlapping Pain Conditions [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/the-problem-of-pain-in-rheumatology-clinical-profiles-associated-with-concomitant-diagnoses-with-chronic-overlapping-pain-conditions/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-problem-of-pain-in-rheumatology-clinical-profiles-associated-with-concomitant-diagnoses-with-chronic-overlapping-pain-conditions/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology